The obese gene product, leptin: Possible role in obesity-related hypertension in adolescents

Journal of Hypertension

Volumn 16, Issue 12 SUPPL., 1998, Pages 2007-2012

  Hirose, Hiroshi ^a   Saito, Ikuo ^a   Tsujioka, Minako ^a   Mori, Masaaki ^a   Kawabe, Hiroshi ^a   Saruta, Takao ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adolescent; Hypertension; Insulin; Leptin; Obesity

Indexed keywords

GENE PRODUCT; GLUCOSE; INSULIN; LEPTIN; LIPID;

ADOLESCENT; ADRENERGIC SYSTEM; ADULT; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEART RATE; HOMEOSTASIS; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0032421732     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199816121-00023     Document Type: Conference Paper

References (39)

1. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988; 37:1595-1607.
2. Kaplan NM: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med 1989; 149:1514-1520.
3. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14:173-194.
4. Anderson EA, Mark AL: The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension 1993; 21:136-141.
5. Kassab S, Kato T, Wilkins FC, Chen R, Hall JE, Granger JP: Renal denervation attenuates the sodium retention and hypertension associated with obesity. Hypertension 1995; 25:893-895.
6. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-432.
7. Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, et al.: Weight-reducing effects of the plasma protein encoded by the obese gene. Science 1995; 269:543-546.
8. Pelleymounter MA, Cullen MJ, Baker MB, Hecht R, Winters D, Boone T. et al.: Effects of the obese gene product on body weight regulation in ob/ob mice. Science 1995; 269:540-543.
9. Campfield LA, Smith FJ, Guisez Y, Devos R, Burn P: Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science 1995; 269:546-549.
10. Weigle DS, Bukowski TR, Foster DC, Holderman S, Kramer JM, Lasser G, et al.: Recombinant ob protein reduces feeding and body weight in the 06/06 mouse. J Clin Invest 1995; 96:2065-2070.
11. Tartaglia LA, Dembski M, Weng X, Deng N, Culpepper J, Devos R, et al.: Identification and expression cloning of a leptin receptor, OB-R. Cell 1995; 83:1263-1271.
12. Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, et al.: Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nature Med 1995; 1:1155-1161.
13. Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, et al.: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 1996; 334:292-295.
14. Hosoda K, Masuzaki H, Ogawa Y, Miyawaki T, Hiraoka J, Hanaoka I, et al.: Development of radioimmunoassay for human leptin. Biochem Biophys Res Commun 1996; 221:234-239.
15. Scherrer U, Sartori C: Insulin as a vascular and sympathoexcitatory hormone:implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997; 96:4104-4113.
16. Collins S, Kuhn CM, Petro AE, Swick AG, Chrunyk BA, Surwit RS: Role of leptin in fat regulation. Nature 1996; 380:677.
17. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI: Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100:270-278.
18. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI: Leptin increases sympathetic nerve activity to blown adipose tissue and kidney. FASEB J 1997; 11:A4.
19. Shek EW, Brands MW, Hall JE: Chronic leptin infusion increases arterial pressure. Hypertension 1998; 31:409-414.
20. Fifth Report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNCV). Arch Intern Med 1993; 153:154-181.
21. Hirose H, Maruyama H, Kido K, Ito K, Koyama K, Tashiro Y, et al.: α- and β-cell function in obese Zucker (fa/fa) rats:a study with the isolated perfused pancreas. Clin Sci 1994; 86:311-316.
22. Yoshida T, Monkawa T, Hayashi M, Saruta T: Regulation of expression of leptin mRNA and secretion of leptin by thyroid hormone in 3T3-L1 adipocytes. Biochem Biophys Res Commun 1997; 232:822-826.
23. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
24. Rudenski AS, Matthews DR, Levy JC, Turner RC: Understanding 'insulin resistance': both glucose resistance and insulin resistance are required to model human diabetes. Metabolism 1991; 40:908-917.
25. Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J: A simple measure of insulin resistance. Lancet 1995; 346:120-121.
26. Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I: Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes 1997; 46:860-867.
27. Cohen B, Novick D, Rubinstein M: Modulation of insulin activities by leptin. Science 1996; 274:1185-1188.
28. Segal KR, Landt M, Klein S: Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996; 45:988-991.
29. Chen G, Koyama K, Yuan X, Lee Y, Zhou YT, O'Doherty R, et al.: Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci USA 1996; 93:14795-14799.
30. Koyama K, Chen G, Wang MY, Lee Y, Shimabukuro M, Newgard CB, et al.: β-Cell function in normal rats made chronically hyperleptinemic by adenovirus-leptin gene therapy. Diabetes 1997; 46:1276-1280.
31. Sivitz WI, Walsh SA, Morgan DA, Thomas MJ, Haynes WG: Effects of leptin on insulin sensitivity in normal rats. Endocrinology 1997; 138:3395-3401.
32. Stirling B, Cox NJ, Bell GI, Hanis CL, Spielman RS, Concannon P: Identification of microsatellite markers near the human ob gene and linkage studies in NIDDM-affected sib pairs. Diabetes 1995; 44:999-1001.
33. Agata J, Masuda A, Takeda M, Higashiura K, Murakami H, Miyazaki Y, et al.: High plasma immunoreactive leptin level in essential hypertension. Am J Hypertens 1997; 10:1171-1174.
34. Reams G, Villarreal D, Taraben A, Freeman RH, Knoblich P: Renal effects of leptin in normotensive and spontaneously hypertensive rats. FASEB J 1997; 11:A258.
35. Vollenweider P, Randin D, Tappy L, Jequier E, Nicod P, Scherrer U: Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. J Clin Invest 1994; 93:2365-2371.
36. Scherrer U, Randin D, Tappy L, Vollenweider P, Jequier E, Nicod P: Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994; 89:2634-2640.
37. Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, et al.: Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25 (part 1):560-563.
38. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M: Plasma leptin and insulin relationships in obese and nonobese humans. Diabetes 1996; 45:695-698.
39. 3-adrenergic receptor inhibits insulin-stimulated leptin secretion from isolated rat adipocytes. Endocrinology 1996; 137:4054-4057.